Dr. Mesa on Ruxolitinib in Chronic Myeloid Leukemia
1 vistas
• 07/08/23
0
0
Empotrar
administrator
Suscriptores
Ruben A. Mesa, MD, Professor of Medicine, Division of Hematology & Medical Oncology, Mayo Clinic, discusses the mechanism of action of ruxolitinib in chronic myeloid leukemia.
More on hematologic malignancies: http://www.onclive.com/special....ty/hematologic-cance
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios